ArticleTherapeutic advances in endocrinology and metabolism2021

Effects of SGLT2 inhibitors on cardiovascular death and all-cause death in patients with type 2 diabetes and chronic kidney disease: an updated meta-analysis including the SCORED trial.

Li-Min Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.